During the past decade, Interventional Cardiology Medical Group conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Interventional Cardiology Medical Group" #1 sponsor was "Bayer" with 3 trials, followed by "American Regent, Inc." with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Idorsia Pharmaceuticals Ltd." with 1 trials sponsored and "Novartis Pharmaceuticals" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Interventional Cardiology Medical Group" #1 collaborator was "Duke Clinical Research Institute" with 2 trials as a collaborator, "Canadian VIGOUR Centre" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Interventional Cardiology Medical Group" are "Heart Failure" (2 trials), "Acute Myocardial Infarction" (1 trials), "Atherosclerotic Cardiovascular Disease" (1 trials), "Atrial Fibrillation" (1 trials) and "Chronic Heart Failure With Preserved Ejection Fraction" (1 trials). Many other conditions were trialed in "Interventional Cardiology Medical Group" in a lesser frequency.

Most popular intervention types in "Interventional Cardiology Medical Group" are "Drug" (6 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials), "Asundexian (BAY2433334)" (1 trials) and "Asundexian matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Interventional Cardiology Medical Group" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Interventional Cardiology Medical Group". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 1 completed trials in Interventional Cardiology Medical Group, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Interventional Cardiology Medical Group, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".